Receive The Newest Study Notifications

New Study Evaluates Ability of Masimo SpHb® (Noninvasive Hemoglobin) to Estimate Timing for Invasive Measurement to Detect Anemia During Surgery

by Lance Smith | May 20, 2019 | Study Scavenger Clinical Trial Recruitment Platform

Masimo  (NASDAQ: MASI) announced today the results of a study published in BMC Anesthesiology in which clinicians at Peking Union Medical College in Beijing evaluated the ability of noninvasive and continuous hemoglobin monitoring with Masimo SpHb ® to help clincians...

SpringWorks Therapeutics Announces Initiation of Phase 3 Trial (DeFi) of Nirogacestat in Adult Patients with Desmoid Tumors

by Lance Smith | May 20, 2019 | Study Scavenger Clinical Trial Recruitment Platform

SpringWorks Therapeutics Announces Initiation of Phase 3 Trial (DeFi) of Nirogacestat in Adult Patients with Desmoid Tumors More STAMFORD, Conn.–(BUSINESS WIRE)– SpringWorks Therapeutics, a clinical-stage biopharmaceutical company focused on developing...

Compugen Doses First Patient in COM701/Opdivo® (Nivolumab) Combination Arm of Phase 1 Study in Patients With Advanced Solid Tumors

by Lance Smith | May 20, 2019 | Study Scavenger Clinical Trial Recruitment Platform

Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and leader in predictive target discovery, today announced that it has dosed the first patient in the combination arm of its Phase 1 study, combining escalating doses of COM701 with a fixed...

Results from Spatz Medical FDA clinical trials confirm that Spatz3, the only Adjustable Gastric Balloon, delivers the highest success rates of all gastric balloons

by Lance Smith | May 20, 2019 | Study Scavenger Clinical Trial Recruitment Platform

 Spatz Medical today announced the FDA trial results of its innovative adjustable gastric balloon. The results demonstrate that the Spatz3 balloon is significantly more effective than any non-adjustable balloon in the market. For the past 30 years, gastric balloons...

HAMLET Pharma Appoints Issa PR to Launch First Major Clinical Trials for a New Cancer Killing Molecule

by Lance Smith | May 20, 2019 | Study Scavenger Clinical Trial Recruitment Platform

The Breakthrough Discovery Using Breast Milk Will Complete in 2019 A research group in Lund, led by Professor Catharina Svanborg, discovered in 1995 that a component of human breast milk kills tumour cells without harming mature, healthy cells. Further experiments and...

Clinical trial participants soar across England

by Lance Smith | May 20, 2019 | Study Scavenger Clinical Trial Recruitment Platform

Numbers have reached record highs with over 870,000 clinical trial participants involved in research studies supported by the National Institute for Health Research (NIHR) over the last year This high number takes significant steps towards the NHS Long Term Plans...